Research analysts at Wells Fargo & Company initiated coverage on shares of Bruker (NASDAQ:BRKR – Get Free Report) in a research note issued on Tuesday, Marketbeat Ratings reports. The firm set an “equal weight” rating and a $72.00 price target on the medical research company’s stock. Wells Fargo & Company‘s price target points to a […]
Wolfe Research began coverage on shares of Bruker (NASDAQ:BRKR – Free Report) in a research report report published on Wednesday, Marketbeat reports. The firm issued an outperform rating and a $80.00 target price on the medical research company’s stock. BRKR has been the subject of a number of other research reports. StockNews.com assumed coverage on […]
BlackRock Inc. cut its holdings in shares of Bruker Co. (NASDAQ:BRKR – Free Report) by 1.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,803,525 shares of the medical research company’s stock after selling 184,562 shares during the quarter. BlackRock Inc. owned […]
Genus Capital Management Inc. acquired a new position in shares of Bruker Co. (NASDAQ:BRKR – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 10,300 shares of the medical research company’s stock, valued at approximately $761,000. Several other […]
Swiss National Bank raised its stake in shares of Bruker Co. (NASDAQ:BRKR – Free Report) by 0.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 223,600 shares of the medical research company’s stock after purchasing an additional 1,400 […]